Clinical Development Medical Director, Obesity and Related Conditions

What you’d do

Serve as Clinical Development Director on late-phase studies of maridebart cafraglutide (AMG 133) in obesity and metabolic disease, reporting to the Global Development Lead for cardiovascular indications. Provide clinical and scientific input into study design, protocols, and the global evidence generation plan. Full time, remote in the United States. Found on the employer's careers page on Oct 19, 2026. Apply through the link.

You’ll need

• MD or DO from an accredited medical school
• 3+ years clinical research experience in biopharma/biotech/CRO
• Late-phase development experience preferred
• Cardiometabolic or adjacent therapeutic area
• US-based remote